Wright Medical Group, Inc. to Participate in the JPMorgan Small/Mid Cap Conference.

ARLINGTON, Tenn. -- Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical device company, announced today that it will be participating in the JPMorgan Small/Mid Cap Conference on Tuesday, November 14 at the Four Seasons Hotel in Boston, Mass. Wright's Executive Vice President and Chief Financial Officer, John K. Bakewell, is scheduled to present at 2:50 p.m. Eastern Time.

A live audio webcast of the presentation will be available on Wright's corporate website at www.wmt.com/corporate, under the "Investor Info" link. The audio webcast will also be archived on this site following the conference.

Wright Medical Group, Inc. is a global orthopaedic medical device company specializing in the design, manufacture and marketing of reconstructive joint devices and biologics. The Company has been in business for more than 50 years and markets its products in over 60 countries worldwide. For more information about Wright Medical, visit our website at www.wmt.com.

This press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements made in this press release, other than statements of historical fact, are forward-looking statements. Forward-looking statements reflect management's current knowledge, assumptions, beliefs, estimates, and expectations and express management's current views of future performance, results, and trends. The Company wishes to caution readers that actual results might differ materially from those described in the forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, including the factors discussed in the Company's filings with the Securities and Exchange Commission (including the Company's annual report on Form 10-K for the year ended December 31, 2005), which could cause the Company's actual results to materially differ from those described in the forward-looking statements. Although the Company believes that the forward-looking statements are accurate, there can be no assurance that any forward-looking statement will prove to be accurate. A forward-looking statement should not be regarded as a representation by the Company that the results described therein will be achieved. The Company wishes to caution readers not to place undue reliance on any forward-looking statement. The forward-looking statements are made as of the date of this press release. The Company assumes no obligation to update any forward-looking statement after this date.